17:21 EDT Oruka Therapeutics (ORKA) files to sell 39.43M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORKA:
- Promising Future for Oruka Therapeutics: Buy Rating Backed by ORKA-002’s Market Potential and Strategic Expansion
- Oruka Therapeutics’ ORKA-002: Promising Alternative with Competitive Edge in Hidradenitis Suppurativa and Psoriasis
- Leerink sees greater opportunity for Oruka’s ORKA-002 after MoonLake news
- Oruka Therapeutics jumps 28% after MoonLake data miss
- Oruka Therapeutics Secures $180M in Private Placement